Jonathan Campbell

[Daniel J Drucker @DanielJDrucker]

@Diabetes_ADA @AmDiabetesAssn Finally Jon Campbell @DukeMedSchool synthesizes gain and loss of GIPR science, reconciling some contradictions while providing a road map for future mechanistic and clinical science to fill in the gaps #weightloss #obesity https://t.co/4w1MTHbh3g @AmDiabetesAssn #diabetes

[Daniel J Drucker @DanielJDrucker]

The intriguing case for GIPR antagonism, supported by genetics, pharmacology and Maritide is presented by Rosenkilde, George, Veniant and Holst #weightloss ##obesity https://t.co/BRYzffz2gU @Diabetes_ADA @AmDiabetesAssn

[Daniel J Drucker @DanielJDrucker]

As we head to the 2025 @AmDiabetesAssn GIP biology will be part of the conversation. Here Samms and Sloop summarize the compelling scientific story of Tirzepatide and the case for GIPR co-agonism #Diabetes #Weightloss #obesity https://t.co/M5UMnAsl0w

[Clair Crewe @CreweLab]

We are looking for a postdoc! If you are interested in obesity/type 2 diabetes and extracellular vesicles apply below!

https://t.co/aInZylwCgH

[Jing Hughes @JingHughes]

It's a beautiful day in the islet neighborhood - check out our review on paracrine actions of primary cilia:
https://t.co/WtJ5wKoAY8

[The Williams Lab @thewilliamslab]

Great lecture and very lively discussion!

[The Williams Lab @thewilliamslab]

Get an updated view on the alpha-cell control of metabolism @UTSWNews Obesity, Metabolism & Diabetes Seminar Series!

Join @JCampbellLab from @DukeMPI for an insightful lecture. Don't miss out! #centerforhypalamicresearch
@UTSWInternalMed

[Jonathan Campbell @JCampbellLab]

@PaulTitchenell @kaheaisu @jclinicalinvest Really nice work Paul. I really like the use of physiological feeding as an intervention. Have you thought about how glucagon touches this pathway and the impact on glycogen?

[Jonathan Campbell @JCampbellLab]

New human data investigating the insulintropic actions of glucagon. https://t.co/Ki9OT7mdow #diabetes

[Jonathan Campbell @JCampbellLab]

@JussherLab Happy Anniversary.

[Randy J. Seeley, Ph.D. @seeleyrj]

Pretty good article on the issues of bariatric surgery in teens. A few quotes from me. https://t.co/nePXgBSh95

[Alexander Bartelt @BarteltLab]

Today I presented our unpublished data on new adipocyte genes and got zero feedback - great success!

[Duke University Gupta Lab @DukeGuptaLab]

https://t.co/syG4uT7TLf

Your fat cells listen and talk. Here, you can read about how surrounding stromal cells in adipose tissue are also getting in on the conversation. New review from @jessicacannavi1 @DukeMPI @dukeendocrinol1

[Jonathan Campbell @JCampbellLab]

@TimoMueller_IDO masterfully describing the new data on GIP and body weight in the 58th Minkowski lecture. Congrats on a well deserved award!

[Helmholtz Diabetes Center (HDC) @helmholtz_diabc]

Congratulations to @TimoMueller_IDO on receiving the the 58th Minkowski Prize Lecture Award at #EASD2023 @DiabResearch #HamburgHall for his groundbreaking #research on energy & #glucose #metabolism regulation via GIP and GIPR:GLP-1R co-agonists. 💡👏

[Jonathan Campbell @JCampbellLab]

Now Dr Erin Mulvihill teaching us about the cardiovascular effects of incretins

[Jonathan Campbell @JCampbellLab]

Jens Holst providing an amazing lecture in the history of incretins. #EASD #diabetes

[Jonathan Campbell @JCampbellLab]

Followed by Prof Fiona Gribble, walking us through the gut production of hormones.

[Filip K. Knop @Filip_Knop]

“Signs of glucagon resistance after a two-week hypercaloric diet intervention”

#T2D #Pathophysiology

Huge amount of experimental work, facinating results and data-driven conclusions beautifully presented by @MalteSuppli in Hamburg Hall #EASD2023🎯🤩👏🏼

https://t.co/1QN7kmWvTt

[Harith Rajagopalan @Harithr]

Fractyl Health’s GLP-1 gene therapy spurs 25% weight loss in obese mice, clinical trials slated for 2024 - https://t.co/ggTMANhJAD